Cesta CE, Rotem R, Bateman BT, et al. JAMA Intern Med. 2024;184:144-152. 38079178.

Download full-text PDF

Source
http://dx.doi.org/10.7326/J24-0015DOI Listing

Publication Analysis

Top Keywords

t2dm periconceptional
4
periconceptional noninsulin
4
noninsulin second-line
4
second-line antidiabetes
4
antidiabetes medications
4
medications linked
4
linked major
4
major congenital
4
congenital malformations
4
malformations insulin
4

Similar Publications

Study Question: What are the roles of maternal preconception diabetes and related periconceptional hyperglycemia on the risk of major congenital malformations (MCMs) in offspring?

Summary Answer: Maternal periconceptional glycated hemoglobin (HbA1c) levels over 5.6% were associated with an increased risk of congenital heart defects (CHD) in the offspring, and maternal preconception diabetes was associated with an increased risk of CHD, including when HbA1c levels were within euglycemic ranges.

What Is Known Already: Maternal preconception diabetes has been linked with MCMs in the offspring.

View Article and Find Full Text PDF

Background: Pregnancy in women with pre-gestational types 1 (T1DM) and 2 (T2DM) diabetes mellitus can be a clinical challenge. This study assessed the association between introducing a structured diabetes in pregnancy proforma, on the quality of medical record documentation and pregnancy outcomes in women with T1DM and T2DM.

Aims: To evaluate the impact of a proforma on the quality of documenting medical records and pregnancy/neonatal outcomes in women with pre-gestational diabetes.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!